查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949463

生物分析檢測服務市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Bioanalytical Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物分析測試服務市場預計將從 2025 年的 50.1 億美元成長到 2031 年的 68.3 億美元，複合年成長率為 5.31%。

這些服務涉及對生物系統中藥物、代謝物和生物標記的定量測量，對於支持藥物研發整體的藥物動力學和毒代動力學研究至關重要。推動該市場成長要素是藥物研發成本的不斷攀升，以及開發需要嚴格安全檢驗的複雜生物製藥和生物相似藥的需求。根據歐洲製藥工業協會聯合會（EFPIA）預測，到2024年，以研發為基礎的製藥業預計將在歐洲的研發領域投入約550億歐元，這筆巨額資金將用於支持日益成長的外包檢測需求，以確保不斷擴大的藥物研發管線符合監管要求。

市場概覽
預測期 2027-2031
市場規模：2025年 50.1億美元
市場規模：2031年 68.3億美元
複合年成長率：2026-2031年 5.31%
成長最快的細分市場 基於細胞的檢測
最大的市場 北美洲

然而，由於能夠執行先進分析方法的專業人員短缺，這項市場擴張面臨巨大的挑戰。大分子檢測所需的複雜性要求具備質譜和配體結合等技術的專業知識。合格人員的短缺造成了營運瓶頸和計劃進度延誤，限制了服務供應商充分利用研發活動成長的機會。

市場促進因素

生物製劑和生物相似藥開發平臺的快速擴張顯著提升了對專業生物分析檢測服務的需求。隨著製藥公司日益重視大分子藥物而非傳統的小分子化合物，對複雜免疫抗原性檢測和藥物動力學分析的需求也顯著增加。這種轉變要求分析平台能夠表徵複雜的蛋白質結構，並確保其安全性符合嚴格的核准標準。根據美國食品藥物管理局（FDA）於2024年1月發布的《2023年新藥核准情況報告》，該機構已核准55種新療法，這一數字凸顯了加速藥物創新和全面實驗室檢驗以支持多元化開發平臺的必要性。

同時，全球臨床試驗數量和複雜性的快速成長是推動生物分析服務普及的關鍵因素。現代臨床研究擴大涉及多區域檢測點和分層患者群體，這需要統一的檢測通訊協定來高效處理海量的生物檢體。日益成長的營運負擔迫使申辦方依賴外部合作夥伴提供的高通量生物分析服務來維護研究的完整性。根據美國國家醫學圖書館2024年5月發布的「趨勢、圖表和地圖」更新報告，ClinicalTrials.gov網站上註冊的臨床試驗累積數量已達492,996項，凸顯了需要支持的研究活動規模之龐大。此外，這種外包趨勢的經濟影響也反映在主要服務供應商的業績上。例如，Icon Plc在2024年2月公佈的年收入為81.202億美元，反映出整個產業對受託研究機構（CRO）的依賴，以應對這些高強度的檢測需求。

市場挑戰

合格人員短缺是全球生物分析檢測服務市場成長的主要障礙。隨著藥物研發轉向複雜的生物製藥和生物相似藥，對先進分析檢測的需求呈現爆炸性成長。然而，這些分子所需的複雜檢測方法需要具備質譜和配體結合等複雜調查方法專業知識的技術人員。當服務供應商缺乏具備這些特定技能的人員時，他們就無法有效率地處理大量樣本，造成營運瓶頸。這會導致計劃交付時間延長，並阻礙合約研究組織 (CRO) 滿足嚴格的監管時限要求。

人才短缺直接阻礙了市場吸收日益成長的外包研究的能力。如果人員不足，測試機構將無法擴大規模以跟上藥物研發的步伐，迫使它們推遲研究啟動並拒絕新契約。據英國製藥工業協會和生物產業協會稱，生命科學產業將在2025年面臨關鍵壓力點，到2035年，還需要新增7萬個工作機會才能滿足產業需求。預期的人才短缺凸顯了日益擴大的技能差距，阻礙了服務供應商充分利用現有資本投資，從而減緩了市場整體擴張的步伐。

市場趨勢

由於細胞和基因療法具有獨特的技術要求，全球生物分析檢測服務市場目前正經歷細胞和基因療法分析服務的激增。這些治療方法與標準生物製藥有著本質差異。與單株抗體不同，細胞和基因療法需要進行專門的檢測，以表徵病毒載體、轉導效率和長期基因組穩定性，這迫使服務供應商投資建造專用的高等級生物安全檢測基礎設施。該行業的成熟度和財務韌性正在推動對這些專業服務的需求。根據再生醫學聯盟發布的《2025年1月產業趨勢簡報》，細胞和基因治療領域的投資正在以30%的速度成長，而這筆巨額資金的湧入直接推動了對複雜生物分析驗證的需求，以支持不斷擴大的開發平臺。

同時，隨著製藥策略向精準醫療和患者分層轉型，生物標記和伴隨診斷檢測的擴展正在重塑市場格局。這一趨勢迫使生物分析實驗室超越傳統的藥物動力學檢測，整合高靈敏度的生物標記檢驗平台，並與臨床試驗同步開發診斷測試。這種轉變帶來的業務擴張在主要產業參與者的表現中清晰可見。根據Labcorp於2025年2月發布的截至2024年12月31日的年度報告，該公司生物製藥實驗室服務部門（涵蓋中心實驗室和生物標記功能）的收入達到29.226億美元，年增5.3%，這主要得益於市場對這些複雜分析服務的自然成長需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球生物分析檢測服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（基於細胞的檢測、細菌細胞檢測、病毒細胞檢測、病毒學檢測、體外病毒學檢測、體內病毒學檢測、物種特異性病毒PCR檢測方法開發、最佳化和檢驗、血清學、免疫抗原性和中和抗體、生物標記檢測、藥物動力學檢測、其他服務）
    • 依應用領域（腫瘤學、神經病學、感染疾病、胃腸病學、心臟病學、其他應用領域）
    • 按最終用戶（製藥/生物製藥公司、合約開發和生產組織、受託研究機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美生物分析檢測服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲生物分析檢測服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區生物分析檢測服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲生物分析檢測服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲生物分析檢測服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球生物分析偵測服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc.
  • ICON plc
  • Charles River Laboratories International, Inc.
  • Covance, Inc.（Labcorp Drug Development）
  • IQVIA Inc
  • Syneos Health Inc
  • SGS SA
  • Intertek Group Plc
  • Pace Analytical Services, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23458

The Global Bioanalytical Testing Services Market is projected to grow from USD 5.01 Billion in 2025 to USD 6.83 Billion by 2031, expanding at a CAGR of 5.31%. These services, which involve the quantitative measurement of drugs, metabolites, and biomarkers in biological systems, are essential for supporting pharmacokinetics and toxicokinetics studies throughout drug development. The market is primarily driven by rising pharmaceutical research expenditures and the need to develop complex biologics and biosimilars that require rigorous safety validation. According to the European Federation of Pharmaceutical Industries and Associations, the research-based pharmaceutical industry invested approximately €55,000 million in R&D in Europe during 2024, a significant financial commitment that underpins the increasing demand for outsourced testing to ensure regulatory compliance for expanding drug pipelines.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.01 Billion
Market Size 2031USD 6.83 Billion
CAGR 2026-20315.31%
Fastest Growing SegmentCell-Based Assays
Largest MarketNorth America

However, this market expansion faces significant challenges due to a shortage of skilled professionals capable of executing advanced analytical methodologies. The complexity of assays required for large molecules necessitates specialized expertise in techniques such as mass spectrometry and ligand binding. A scarcity of qualified personnel leads to operational bottlenecks and delays in project timelines, limiting the ability of service providers to fully capitalize on the growing volume of research activities.

Market Driver

The rapid expansion of biologics and biosimilars development pipelines significantly reinforces the demand for specialized bioanalytical testing services. As pharmaceutical companies increasingly prioritize large molecule therapeutics over traditional small molecules, there is a substantial rise in the requirement for intricate immunogenicity testing and pharmacokinetic assays. This transition necessitates analytical platforms capable of characterizing complex protein structures and ensuring safety profiles meet rigorous standards for approval. According to the U.S. Food and Drug Administration's 'Novel Drug Approvals for 2023' report released in January 2024, the agency approved 55 novel therapeutics, a figure that underscores the accelerating pace of drug innovation and the consequential need for comprehensive laboratory validation to support these diverse pipelines.

Concurrently, the surge in global clinical trial volume and complexity acts as a critical driver for bioanalytical service adoption. Modern clinical studies increasingly involve multi-regional sites and stratified patient populations, requiring harmonized testing protocols to efficiently process vast quantities of biological samples. This escalating operational burden compels sponsors to rely on external partners for high-throughput bioanalysis to maintain study integrity. According to the National Library of Medicine's 'Trends, Charts, and Maps' update in May 2024, the cumulative number of registered clinical studies on ClinicalTrials.gov reached 492,996, highlighting the immense scale of research activities requiring support. Furthermore, the financial magnitude of this outsourcing trend is evident in the performance of major service providers; Icon Plc, for instance, reported a full-year revenue of $8,120.2 million in February 2024, reflecting the industry-wide reliance on contract research organizations to manage these intensive testing requirements.

Market Challenge

The scarcity of qualified personnel poses a substantial barrier to the growth of the global bioanalytical testing services market. As pharmaceutical development shifts toward complex biologics and biosimilars, the demand for advanced analytical testing has surged. However, the sophisticated assays required for these molecules demand technicians with specialized expertise in intricate methodologies like mass spectrometry and ligand binding. When service providers lack a workforce with these specific competencies, they struggle to process sample volumes efficiently, creating operational bottlenecks that extend project turnaround times and compromise the ability of contract research organizations to meet rigorous regulatory timelines.

This workforce constraint directly impedes the market's capacity to absorb the rising volume of outsourced research. Without adequate staffing, testing facilities cannot scale operations to match the pace of drug discovery, forcing them to delay study initiations or decline new contracts. According to the Association of the British Pharmaceutical Industry and the BioIndustry Association, the life sciences sector faces a critical pressure point in 2025, where an additional 70,000 jobs will be required by 2035 to meet industry demand. This projected shortfall highlights a widening skills gap that restricts service providers from fully leveraging available capital investments, thereby slowing the overall trajectory of market expansion.

Market Trends

The Global Bioanalytical Testing Services Market is currently experiencing a surge in cell and gene therapy analytical services, driven by the unique technical requirements of these advanced modalities which differ fundamentally from standard biologics. Unlike monoclonal antibodies, cell and gene therapies require specialized testing for viral vector characterization, transduction efficiency, and long-term genomic stability, compelling service providers to invest in dedicated, high-containment testing infrastructures. The maturation and financial resilience of this sector are accelerating these specialized service needs; according to the Alliance for Regenerative Medicine's 'State of the Industry Briefing' in January 2025, investment in the cell and gene therapy sector rose by 30 percent, a significant capital influx that directly fuels the demand for intricate bioanalytical validation to support expanding development pipelines.

Concurrently, the market is defined by the expansion of biomarker and companion diagnostic testing as pharmaceutical strategies increasingly pivot toward precision medicine and patient stratification. This trend forces bioanalytical laboratories to evolve beyond traditional pharmacokinetic assays, requiring the integration of high-sensitivity platforms for biomarker validation and the co-development of diagnostic assays that run parallel to clinical studies. The operational growth resulting from this shift is evident in the performance of major industry players; according to Labcorp's 'Annual Report for Fiscal Year Ending 12/31, 2024' released in February 2025, the company's Biopharma Laboratory Services segment, which encompasses central laboratory and biomarker capabilities, achieved a revenue of $2,922.6 million, representing a 5.3 percent increase driven by organic demand for these complex analytical services.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • ICON plc
  • Charles River Laboratories International, Inc.
  • Covance, Inc. (Labcorp Drug Development)
  • IQVIA Inc
  • Syneos Health Inc
  • SGS S.A.
  • Intertek Group Plc
  • Pace Analytical Services, LLC

Report Scope

In this report, the Global Bioanalytical Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioanalytical Testing Services Market, By Type

  • Cell-based Assays
  • Bacterial cell-based assays
  • Viral cell-based assays
  • Virology Testing
  • In Vitro Virology Testing
  • In Vivo Virology Testing
  • Species-specific Viral PCR Assays Method Development
  • Optimization and Validation
  • Serology
  • Immunogenicity and Neutralizing Antibodies
  • Biomarker Testing
  • Pharmacokinetic Testing
  • Other Services

Bioanalytical Testing Services Market, By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology
  • Other Applications

Bioanalytical Testing Services Market, By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Development and Manufacturing Organizations
  • Contract Research Organizations

Bioanalytical Testing Services Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioanalytical Testing Services Market.

Available Customizations:

Global Bioanalytical Testing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioanalytical Testing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cell-based Assays, Bacterial cell-based assays, Viral cell-based assays, Virology Testing, In Vitro Virology Testing, In Vivo Virology Testing, Species-specific Viral PCR Assays Method Development, Optimization and Validation, Serology, Immunogenicity and Neutralizing Antibodies, Biomarker Testing, Pharmacokinetic Testing, Other Services)
    • 5.2.2. By Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, Other Applications)
    • 5.2.3. By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Bioanalytical Testing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bioanalytical Testing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bioanalytical Testing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bioanalytical Testing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bioanalytical Testing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Bioanalytical Testing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Bioanalytical Testing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bioanalytical Testing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bioanalytical Testing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bioanalytical Testing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Bioanalytical Testing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Bioanalytical Testing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bioanalytical Testing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bioanalytical Testing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bioanalytical Testing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bioanalytical Testing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Bioanalytical Testing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Bioanalytical Testing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Bioanalytical Testing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Bioanalytical Testing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Bioanalytical Testing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bioanalytical Testing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Bioanalytical Testing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Bioanalytical Testing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Bioanalytical Testing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. ICON plc
  • 15.3. Charles River Laboratories International, Inc.
  • 15.4. Covance, Inc. (Labcorp Drug Development)
  • 15.5. IQVIA Inc
  • 15.6. Syneos Health Inc
  • 15.7. SGS S.A.
  • 15.8. Intertek Group Plc
  • 15.9. Pace Analytical Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer